(Q38807828)

https://doi.org/10.3892/mmr.2022.12630

6 September 2017

1 reference

29 December 2023

title

Knockdown of PREX2a inhibits the malignant phenotype of osteosarcoma cells (English)

1 reference

6 September 2017

Zixun Dai

1

1 reference

6 September 2017

Jie Xie

series ordinal

2

1 reference

6 September 2017

Pengfei Lei

series ordinal

3

1 reference

6 September 2017

Yihe Hu

series ordinal

4

1 reference

6 September 2017

publication date

28 December 2015

1 reference

Molecular Medicine Reports

6 September 2017

published in

1 reference

6 September 2017

volume

13

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

1930-1936

1 reference

miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a.

6 September 2017

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

PI3K keeps the balance between metabolism and cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Melanoma genome sequencing reveals frequent PREX2 mutations

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

P-Rex2 regulates Purkinje cell dendrite morphology and motor coordination

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

PTEN: one gene, many syndromes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Modulation of the osteosarcoma expression phenotype by microRNAs

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

GDC-0152 attenuates the malignant progression of osteosarcoma promoted by ANGPTL2 via PI3K/AKT but not p38MAPK signaling pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Manipulation therapy prior to diagnosis induced primary osteosarcoma metastasis--from clinical to basic research

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

New molecular insights into osteosarcoma targeted therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

P-REX2a driving tumorigenesis by PTEN inhibition

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

P-REX2, a novel PI-3-kinase sensitive Rac exchange factor.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Molecular pathways: P-Rex in cancer.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

P-Rex2, a new guanine-nucleotide exchange factor for Rac

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3892/MMR.2015.4728

Identifiers

DOI

10.3892/MMR.2015.4728

1 reference

6 September 2017

1 reference